TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 2 | -6 | -8 | -5 | 7 | -5 | 0 | -3 |
| S | %wins | 100 | 100 | 100 | 0 | 100 | 80 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/9/17 21:11 | 6/7/17 | KITE | Kite Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Doumani Roy | CA | D | S.m | -1,267 | 84.48 | 0 | -15 | -8 | 175 | D | |||||||||||||||
3/2/17 06:06 | 3/1/17 | KITE | Kite Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Doumani Roy | CA | D | S.d | -1,400 | 74.46 | 33 | -19 | -16 | 100 | M | 24 | 56 | 37 | 65 | 67 | 52 | 46 | 51 | -6 | -5 | -2 | ||||
6/8/16 19:27 | 6/6/16 | KITE | Kite Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Doumani Roy | CA | D | S | -813 | 58.04 | 33 | -14 | -8 | 159 | M | -10 | -20 | 9 | 18 | 28 | 17 | 2 | -5 | -10 | -7 | 7 | -5 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |